Auxilium Pharmaceuticals Inc. (AUXL)
-NasdaqGS 15.01 
0.04(0.27%) May 17, 4:00PM EDT|After Hours
:
15.01 0.00 (0.00%) May 17, 4:32PM EDT
| Prev Close: | 15.05 |
|---|
| Open: | 15.26 |
|---|
| Bid: | 11.53 x 100 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 20.69 |
|---|
| Beta: | 0.94 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 14.99 - 15.34 |
|---|
| 52wk Range: | 13.87 - 29.37 |
|---|
| Volume: | 828,141 |
|---|
| Avg Vol (3m): | 787,800 |
|---|
| Market Cap: | 739.36M |
|---|
| P/E (ttm): | 9.37 |
|---|
| EPS (ttm): | 1.60 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Auxilium Pharmaceuticals, Inc. To Present At The UBS Global Health Care ConferencePR Newswire(Wed, May 15)
- AUXILIUM PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Wed, May 15)
- Auxilium Pharmaceuticals, Inc. To Present At The Bank Of America Merrill Lynch 2013 Health Care ConferencePR Newswire(Fri, May 10)
- Sell in May, But Don't Go Awayat Motley Fool(Wed, May 8)
- AUXILIUM PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Mon, May 6)
- AUXILIUM PHARMACEUTICALS INC FinancialsEDGAR Online Financials(Sat, May 4)
- Analyst Moves: BEAM, AUXL, SPFat Forbes(Fri, May 3)
- Stock Upgrades: Make a Mint (Julep) in Jim Beam Ahead of Kentucky Derbyat Minyanville(Fri, May 3)
- 3 Healthcare Stocks to Avoidat Motley Fool(Thu, May 2)
- Key for Big Generic Players is Focusing on Higher Value Opportunities that Provide Sustainable Cash Flows: Expert Analyst David Amsellem Discusses the Pharmaceutical Sector with The Wall Street TranscriptWall Street Transcript(Thu, May 2)
- Weak Quarter At Auxilium Overshadows Execution On Long-Term Strategyat Seeking Alpha(Wed, May 1)
- Best Buy Is a Buy and 3 More Analyst Upgrades To Knowat Wall St. Cheat Sheet(Tue, Apr 30)
- Wider Loss at Auxilium, Acquires ActientZacks(Tue, Apr 30)
- The Morning Leverage: A Testosterone-Fueled Exit for GTCRat The Wall Street Journal(Tue, Apr 30)
- Auxilium Pharma upgraded by StifelBriefing.com(Tue, Apr 30)
Key Statistics
| Forward P/E (1 yr): | 36.61 |
|---|
| P/S (ttm): | 1.91 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.16 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.06 |
|---|
| Mean Recommendation*: | 2.1 |
|---|
| PEG Ratio (5 yr expected): | -3.14 |
|---|
Business Summary
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, together with its subsidiaries, develops and markets pharmaceutical products worldwide.
View More